Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]

Thrombolysis and mechanical thrombectomy have revolutionized the care of patients with acute ischemic stroke. The number of patients who can benefit from these treatments continues to increase as new studies demonstrate that not just time since stroke onset but also collateral circulation influences...

Full description

Bibliographic Details
Main Authors: Nicholas Liaw, David Liebeskind
Format: Article
Language:English
Published: F1000 Research Ltd 2020-06-01
Series:F1000Research
Online Access:https://f1000research.com/articles/9-546/v1
id doaj-f2f6a59090e8429e8f93c6a466054993
record_format Article
spelling doaj-f2f6a59090e8429e8f93c6a4660549932020-11-25T03:56:13ZengF1000 Research LtdF1000Research2046-14022020-06-01910.12688/f1000research.21100.123223Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]Nicholas Liaw0David Liebeskind1Department of Vascular Neurology, University of California, Los Angeles, 635 Charles E Young Drive South, Suite 225, Los Angeles, California, 90095-7334, USADepartment of Vascular Neurology, University of California, Los Angeles, 635 Charles E Young Drive South, Suite 225, Los Angeles, California, 90095-7334, USAThrombolysis and mechanical thrombectomy have revolutionized the care of patients with acute ischemic stroke. The number of patients who can benefit from these treatments continues to increase as new studies demonstrate that not just time since stroke onset but also collateral circulation influences outcome. Technologies such as telestroke, mobile stroke units, and artificial intelligence are playing an increasing role in identifying and treating stroke. Stroke-systems-of-care models continue to streamline the delivery of definitive revascularization in the age of mechanical thrombectomy.https://f1000research.com/articles/9-546/v1
collection DOAJ
language English
format Article
sources DOAJ
author Nicholas Liaw
David Liebeskind
spellingShingle Nicholas Liaw
David Liebeskind
Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]
F1000Research
author_facet Nicholas Liaw
David Liebeskind
author_sort Nicholas Liaw
title Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]
title_short Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]
title_full Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]
title_fullStr Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]
title_full_unstemmed Emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]
title_sort emerging therapies in acute ischemic stroke [version 1; peer review: 3 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2020-06-01
description Thrombolysis and mechanical thrombectomy have revolutionized the care of patients with acute ischemic stroke. The number of patients who can benefit from these treatments continues to increase as new studies demonstrate that not just time since stroke onset but also collateral circulation influences outcome. Technologies such as telestroke, mobile stroke units, and artificial intelligence are playing an increasing role in identifying and treating stroke. Stroke-systems-of-care models continue to streamline the delivery of definitive revascularization in the age of mechanical thrombectomy.
url https://f1000research.com/articles/9-546/v1
work_keys_str_mv AT nicholasliaw emergingtherapiesinacuteischemicstrokeversion1peerreview3approved
AT davidliebeskind emergingtherapiesinacuteischemicstrokeversion1peerreview3approved
_version_ 1724466331881832448